A Study Comparing Amounts of 2 Different Forms of Tafamidis (PF-6291826) in the Blood
NCT03266705
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
tafamidis
Sponsor
Pfizer